Skip Nav Destination
Issues
1 January 1998
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Minireview
Advances in Brief
Research Articles
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
N Dawson; W D Figg; O W Brawley; R Bergan; M R Cooper; A Senderowicz; D Headlee; S M Steinberg; M Sutherland; N Patronas; E Sausville; W M Linehan; E Reed; O Sartor
Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
V I Avramis; S Wiersma; M D Krailo; L V Ramilo-Torno; A Sharpe; W Liu-Mares; R Kowck; G H Reaman; J K Sato
Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
V M Whitehead; M J Vuchich; L Cooley; S J Lauer; D H Mahoney; J J Shuster; C Payment; M L Bernstein; J J Akabutu; T Bowen; B A Kamen; M S Watson; A T Look; D J Pullen; B Camitta
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
G Fontanini; M De Laurentiis; S Vignati; S Chinè; M Lucchi; V Silvestri; A Mussi; S De Placido; G Tortora; A R Bianco; W Gullick; C A Angeletti; G Bevilacqua; F Ciardiello
Letter to the Editor
Advertisement